EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells

Gabriele Favaretto iD, Marianna Nicoletta Rossi iD, Lorenzo Cuollo iD, Mattia Laffranchi iD, Manuela Cervelli iD, Alessandra Soriani iD, Silvano Sozzani iD, Angela Santoni iD, Fabrizio Antonangeli iD

Cancer Immunology, Immunotherapy · 02.05.2024 · 73 (6)

DOI: 10.1007/s00262-024-03695-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 02.05.2024. Verfasst von Gabriele Favaretto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), c/o Department of Molecular Medicine, Sapienza University of Ro…. Hauptthemen laut MEDLINE: Piperazines, Pyridines, Cellular Senescence, Breast Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Sapienza Università di Roma, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Senescent cells have a profound impact on the surrounding microenvironment through the secretion of numerous bioactive molecules and inflammatory factors. The induction of therapy-induced senescence by anticancer drugs is known, but how senescent tumor cells influence the tumor immune landscape, particularly neutrophil activity, is still unclear. In this study, we investigate the induction of cellular senescence in breast cancer cells and the subsequent immunomodulatory effects on neutrophils using the CDK4/6 inhibitor palbociclib, which is approved for the treatment of breast cancer and is under intense investigation for additional malignancies. Our research demonstrates that palbociclib induces a reversible form of senescence endowed with an inflammatory secretome capable of recruiting and activating neutrophils, in part through the action of interleukin-8 and acute-phase serum amyloid A1. The activation of neutrophils is accompanied by the release of neutrophil extracellular trap and the phagocytic removal of senescent tumor cells. These findings may be relevant for the success of cancer therapy as neutrophils, and neutrophil-driven inflammation can differently affect tumor progression. Our results reveal that neutrophils, as already demonstrated for macrophages and natural killer cells, can be recruited and engaged by senescent tumor cells to participate in their clearance. Understanding the interplay between senescent cells and neutrophils may lead to innovative strategies to cope with chronic or tumor-associated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesPyridinesCellular SenescenceBreast NeoplasmsNeutrophilsHumansFemaleCell Line, TumorNeutrophil ActivationTumor Microenvironment

Stichwörter der Autor:innen

Breast cancerNETNeutrophilPalbociclibSASPSenescenceSerum amyloid A

Substanzen

palbociclibPiperazinesPyridines

Autor:innen und Institutionen

  • Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), c/o Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.
  • Department of Science, Roma Tre University, Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Pediatrics, Columbia University, New York, NY, USA.
  • Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
  • IRCCS Neuromed, Pozzilli, Italy.

ORCID-Profile: Gabriele Favaretto, Marianna Nicoletta Rossi, Lorenzo Cuollo, Mattia Laffranchi, Manuela Cervelli, Alessandra Soriani, Silvano Sozzani, Angela Santoni, Fabrizio Antonangeli

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Sapienza Università di Roma
  • Pfizer
  • Consiglio Nazionale delle Ricerche
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Favaretto, G., Rossi, M. N., Cuollo, L., Laffranchi, M., Cervelli, M., Soriani, A., Sozzani, S., Santoni, A., & Antonangeli, F. (2024). Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells. Cancer Immunology, Immunotherapy, 73(6). https://doi.org/10.1007/s00262-024-03695-5

Vancouver

Favaretto G, Rossi MN, Cuollo L, Laffranchi M, Cervelli M, Soriani A, et al. Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells. Cancer Immunology, Immunotherapy. 2024;73(6). doi:10.1007/s00262-024-03695-5

BibTeX
@article{Favaretto2024,
  author = {Favaretto, Gabriele and Rossi, Marianna Nicoletta and Cuollo, Lorenzo and Laffranchi, Mattia and Cervelli, Manuela and Soriani, Alessandra and Sozzani, Silvano and Santoni, Angela and Antonangeli, Fabrizio},
  title = {Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  volume = {73},
  number = {6},
  doi = {10.1007/s00262-024-03695-5}
}
Kostenlos starten →